Note from the Editor

Rees, Margaret
September 2007
Menopause International;Sep2007, Vol. 13 Issue 3, p91
Academic Journal
The article discusses papers published within this issue, including one by Van Geel and colleagues on the risk of all clinical fractures and another by Louie Atkins and Lesley Fallowfield on the impact of cancer, cancer risk, menopausal status and psychological factors on sexual activity.


Related Articles

  • HRT raises risk of rare, treatable breast cancer. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);06/19/99, Vol. 318 Issue 7199, p1645 

    Reveals that hormone replacement therapy after menopause raises the risks of uncommon forms of breast cancer. Background on a related study conducted by the Northwestern Medical School in Chicago, Illinois; Risk of women who used hormones compared to those who did not.

  • Hormone replacement and breast cancer: Balancing the risks. Pinkowish, Mary Desmond // Patient Care;4/15/2000, Vol. 34 Issue 7, p26 

    Suggests that the long-term use of hormone replacement therapy (HRT) may be associated with a significantly increased risk of breast cancer. Need for women and their doctors to discuss possible risks before making a decision about postmenopausal hormone therapy; Highlights of the Breast Cancer...

  • Mammography affected by hormone replacement therapy. Blume, Elaine // JNCI: Journal of the National Cancer Institute;05/15/96, Vol. 88 Issue 10, p638 

    Reports on the possibility that hormone replacement therapy in menopausal women may increase the risk for breast cancer. Difficulty of interpreting mammograms due to estrogen intake; Increase in likelihood of false-positive and false-negative mammographic readings.

  • Breast cancer and hormonal supplements in postmenopausal women. McPherson, Klim // BMJ: British Medical Journal (International Edition);9/16/95, Vol. 311 Issue 7007, p699 

    Focuses on the use of hormone supplements in relieving menopausal symptoms. Measurement of the effect of estrogen; Risk of breast cancers for women using hormone supplements; Attributable effects of combined supplements on deaths from heart disease.

  • Breast cancer risk of post-menopausal estrogen can be mitigated.  // Modern Medicine;May98, Vol. 66 Issue 5, p60 

    Presents an abstract of the article `Does Postmenopausal Estrogen Administration Increase the Risk of Breast Cancer? Contributions of Animal, Biochemical and Clinical Investigative Studies to a Resolution of the Controversy,' by Zumoff B from `Proceedings of the Society for Experimental Biology...

  • High bone mass, breast cancer linked in postmenopausal women.  // Geriatrics;May97, Vol. 52 Issue 5, p18 

    Reports that high bone mass in middle-aged and older women is a strong predictor of postmenopausal breast cancer, according to the results of a study funded by the National Institutes of Health (NIH). Explanations of investigator Douglas P. Kiel about breast cancer risk factors; Incidence rates...

  • Lifetime exercise activity and breast cancer risk among post-menopausal women. Carpenter, C L; Ross, R K; Paganini-Hill, A; Bernstein, L // British Journal of Cancer;8/1/99, Vol. 80 Issue 11, p1852 

    Lifetime exercise activity has been linked to breast cancer risk among young women. However, no study has specifically evaluated whether lifetime exercise activity is related to the breast cancer risk of post-menopausal women. We conducted a population-based case-control study of post-menopausal...

  • Estrogen use: Does it or doesn't it increase breast cancer risk?  // Modern Medicine;Aug94, Vol. 62 Issue 8, p6 

    Reports on the risk of breast cancer with postmenopausal estrogen use. Incidence among women who have taken estrogen; Effects of combined estrogen and progestin use among middle-aged women; Results of the the Nurses' Health Study and case-control study conducted in King County, Washington.

  • Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Harriet Johansson; Sara Gandini; Bernardo Bonanni; Frederique Mariette; Aliana Guerrieri-Gonzaga; Davide Serrano; Enrico Cassano; Francesca Ramazzotto; Laura Baglietto; Maria Sandri // Breast Cancer Research & Treatment;Mar2008, Vol. 108 Issue 1, p57 

    Abstract Background  Endogenous hormones and insulin-like growth factors (IGF) play a central role in breast cancer development. Mammographic density, an important breast cancer risk factor, has been associated with these biomarkers in premenopausal women. The aim of this study was to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics